A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
This randomized phase II study compare survival outcomes and toxicity of malignant pleural
effusion stage IV non small-cell lung cancer patients Intrapleural infusion chemotherapy in
combination with concurrent thoracic radiation therapy (TRT) VS not combination with
concurrent thoracic radiation therapy (TRT).